Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis

References

• Danbolt NC. Glutamate uptake. Prog. Neurobiol.65(1), 1–105 (2001).
   PubMed Web of Science ®Google Scholar
• Choi DW. Excitotoxic cell death. J. Neurobiol.23(9), 1261–1276 (1992).
   PubMedGoogle Scholar
• Olney JW. Excitotoxicity: an overview. Can. Dis. Wkly Rep.16(Suppl. 1E), 47–57; discussion 57–58 (1990).
   PubMedGoogle Scholar
• Ganor Y, Besser M, Ben-Zakay N, Unger T, Levite M. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration. J. Immunol.170(8), 4362–4372 (2003).
   PubMed Web of Science ®Google Scholar
• Miglio G, Varsaldi F, Lombardi G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem. Biophys. Res. Commun.338(4), 1875–1883 (2005).
   PubMedGoogle Scholar
• Boldyrev AA, Carpenter DO, Johnson P. Emerging evidence for a similar role of glutamate receptors in the nervous and immune systems. J. Neurochem.95(4), 913–918 (2005).
   PubMed Web of Science ®Google Scholar
• Ganor Y, Freilinger M, Dulac O, Levite M. Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokines. Autoimmunity38(2), 139–150 (2005).
   PubMed Web of Science ®Google Scholar
• Rogers SW, Andrews PI, Gahring LC et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen’s encephalitis. Science265(5172), 648–651 (1994).
   PubMed Web of Science ®Google Scholar
• Andrews PI, Dichter MA, Berkovic SF, Newton MR, McNamara JO. Plasmapheresis in Rasmussen’s encephalitis. Neurology46(1), 242–246 (1996).
   PubMed Web of Science ®Google Scholar
• Twyman RE, Gahring LC, Spiess J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron14(4), 755–762 (1995).
   PubMed Web of Science ®Google Scholar
• Antozzi C, Granata T, Aurisano N et al. Long-term selective IgG immuno-adsorption improves Rasmussen’s encephalitis. Neurology51(1), 302–305 (1998).
   PubMed Web of Science ®Google Scholar
• Wiendl H, Bien CG, Bernasconi P et al. GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen’s encephalitis. Neurology57(8), 1511–1514 (2001).
   PubMed Web of Science ®Google Scholar
• Mantegazza R, Bernasconi P, Baggi F et al. Antibodies against GluR3 peptides are not specific for Rasmussen’s encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J. Neuroimmunol.131(1–2), 179–185 (2002).
   PubMedGoogle Scholar
• Baranzini SE, Laxer K, Saketkhoo R et al. Analysis of antibody gene rearrangement, usage, and specificity in chronic focal encephalitis. Neurology58(5), 709–716 (2002).
   PubMed Web of Science ®Google Scholar
• Ganor Y, Goldberg-Stern H, Amromd D et al. Autoimmune epilepsy: some epilepsy patients harbor autoantibodies to glutamate receptors and dsDNA on both sides of the blood-brain barrier, which may kill neurons and decrease in brain fluids after hemispherotomy. Clin. Dev. Immunol.11(3–4), 241–252 (2004).
   PubMedGoogle Scholar
• Ganor Y, Goldberg-Stern H, Lerman-Sagie T, Teichberg VI, Levite M. Autoimmune epilepsy: distinct subpopulations of epilepsy patients harbor serum autoantibodies to either glutamate/AMPA receptor GluR3, glutamate/NMDA receptor subunit NR2A or double-stranded DNA. Epilepsy Res.65(1–2), 11–22 (2005).
   PubMed Web of Science ®Google Scholar
• Roubertie A, Boukhaddaoui H, Sieso V et al. Antiglial cell autoantibodies and childhood epilepsy: a case report. Epilepsia46(8), 1308–1312 (2005).
   PubMedGoogle Scholar
• Feichtinger M, Wiendl H, Korner E et al. No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3-antibodies. Seizure15(5), 350–354 (2006).
   PubMedGoogle Scholar
• Solaro C, Mantegazza R, Bacigalupo A, Uccelli A. Intractable myoclonus associated with anti-GluR3 antibodies after allogeneic bone marrow transplantation. Haematologica91(12 Suppl.), ECR62 (2006).
   PubMedGoogle Scholar
• Tziperman B, Garty BZ, Schoenfeld N et al. Acute intermittent porphyria, Rasmussen encephalitis, or both? J. Child Neurol.22(1), 99–105 (2007).
   PubMed Web of Science ®Google Scholar
• Carlson NG, Gahring LC, Rogers SW. Identification of the amino acids on a neuronal glutamate receptor recognized by an autoantibody from a patient with paraneoplastic syndrome. J. Neurosci. Res.63(6), 480–485 (2001).
   PubMedGoogle Scholar
• Gahring LC, Twyman RE, Greenlee JE, Rogers SW. Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Mol. Med.1(3), 245–253 (1995).
   PubMed Web of Science ®Google Scholar
• Gahring LC, Rogers SW, Twyman RE. Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration. Neurology48(2), 494–500 (1997).
   PubMedGoogle Scholar
• DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat. Med.7(11), 1189–1193 (2001).
   PubMed Web of Science ®Google Scholar
• Husebye ES, Sthoeger ZM, Dayan M et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann. Rheum. Dis.64(8), 1210–1213 (2005).
   PubMed Web of Science ®Google Scholar
• Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur. J. Neurol.12(5), 392–398 (2005).
   PubMed Web of Science ®Google Scholar
• Lapteva L, Nowak M, Yarboro CH et al. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum.54(8), 2505–2514 (2006).
   PubMed Web of Science ®Google Scholar
• Hanly JG, Robichaud J, Fisk JD. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J. Rheumatol.33(8), 1553–1558 (2006).
   PubMed Web of Science ®Google Scholar
• Harrison MJ, Ravdin LD, Lockshin MD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum.54(8), 2515–2522 (2006).
   PubMed Web of Science ®Google Scholar
• Takahashi Y, Mori H, Mishina M et al. Autoantibodies to NMDA receptor in patients with chronic forms of epilepsia partialis continua. Neurology61(7), 891–896 (2003).
   PubMedGoogle Scholar
• Takahashi Y, Mori H, Mishina M et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia46(Suppl. 5), 152–158 (2005).
   PubMedGoogle Scholar
• Sansing LH, Tuzun E, Ko MW, Baccon J, Lynch DR, Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat. Clin. Pract. Neurol.3(5), 291–296 (2007).
   PubMedGoogle Scholar
• Dalmau J, Tuzun E, Wu HY et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann. Neurol.61(1), 25–36 (2007).
   PubMed Web of Science ®Google Scholar
• Okamoto S, Hirano T, Takahashi Y, Yamashita T, Uyama E, Uchino M. Paraneoplastic limbic encephalitis caused by ovarian teratoma with autoantibodies to glutamate receptor. Intern. Med.46(13), 1019–1022 (2007).
   PubMedGoogle Scholar
• Iizuka T, Sakai F, Ide T et al. Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal. Neurology70(7), 504–511 (2008).
   PubMed Web of Science ®Google Scholar
• Nakajima H, Hosoya M, Takahashi Y et al. A chronic progressive case of enteroviral limbic encephalitis associated with autoantibody to glutamate receptor epsilon2. Eur. Neurol.57(4), 238–240 (2007).
   PubMedGoogle Scholar
• Kimura A, Sakurai T, Suzuki Y et al. Autoantibodies against glutamate receptor epsilon2-subunit detected in a subgroup of patients with reversible autoimmune limbic encephalitis. Eur. Neurol.58(3), 152–158 (2007).
   PubMedGoogle Scholar
• Mochizuki Y, Mizutani T, Isozaki E, Ohtake T, Takahashi Y. Acute limbic encephalitis: a new entity? Neurosci. Lett.394(1), 5–8 (2006).
   PubMedGoogle Scholar
• Takahashi Y. Infections as causative factors of epilepsy. Future Neurol.1(3), 291–302 (2006).
   Google Scholar
• Dambinova SA, Khounteev GA, Izykenova GA, Zavolokov IG, Ilyukhina AY, Skoromets AA. Blood test detecting autoantibodies to N-methyl-d-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem.49(10), 1752–1762 (2003).
   PubMed Web of Science ®Google Scholar
• Billiau AD, Wouters CH, Lagae LG. Epilepsy and the immune system: is there a link? Eur. J. Paediatr. Neurol.9(1), 29–42 (2005).
   PubMed Web of Science ®Google Scholar
• Levite M. Autoimmune epilepsy. Nat. Immunol.3(6), 500 (2002).
   PubMedGoogle Scholar
• Rasmussen T, Olszewski J, Lloydsmith D. Focal seizures due to chronic localized encephalitis. Neurology8(6), 435–445 (1958).
   PubMed Web of Science ®Google Scholar
• Watson R, Jiang Y, Bermudez I et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology63(1), 43–50 (2004).
   PubMedGoogle Scholar
• Bernasconi P, Cipelletti B, Passerini L et al. Similar binding to glutamate receptors by Rasmussen and partial epilepsy patients’ sera. Neurology59(12), 1998–2001 (2002).
   PubMedGoogle Scholar
• Levite M, Fleidervish IA, Schwarz A, Pelled D, Futerman AH. Autoantibodies to the glutamate receptor kill neurons via activation of the receptor ion channel. J. Autoimmun.13(1), 61–72 (1999).
   PubMed Web of Science ®Google Scholar
• Levite M, Hermelin A. Autoimmunity to the glutamate receptor in mice – a model for Rasmussen’s encephalitis? J. Autoimmun.13(1), 73–82 (1999).
   PubMedGoogle Scholar
• Cohen-Kashi Malina K, Ganor Y, Levite M, Teichberg VI. Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channels. Neurochem. Res.31(10), 1181–1190 (2006).
   PubMedGoogle Scholar
• Frassoni C, Spreafico R, Franceschetti S et al. Labeling of rat neurons by anti-GluR3 IgG from patients with Rasmussen encephalitis. Neurology57(2), 324–327 (2001).
   PubMedGoogle Scholar
• Carlson NG, Gahring LC, Twyman RE, Rogers SW. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation. J. Biol. Chem.272(17), 11295–11301 (1997).
   PubMed Web of Science ®Google Scholar
• Koustova E, Sei Y, Fossom L et al. LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor. J. Clin. Invest.107(6), 737–744 (2001).
   PubMedGoogle Scholar
• Gahring LC, Rogers SW. Autoimmunity to glutamate receptors in the central nervous system. Crit. Rev. Immunol.22(4), 295–316 (2002).
   PubMedGoogle Scholar
• Stern-Bach Y, Bettler B, Hartley M, Sheppard PO, O’Hara PJ, Heinemann SF. Agonist selectivity of glutamate receptors is specified by two domains structurally related to bacterial amino acid-binding proteins. Neuron13(6), 1345–1357 (1994).
   PubMed Web of Science ®Google Scholar
• Basile AS, Koustova E, Ioan P, Rizzoli S, Rogawski MA, Usherwood PN. IgG isolated from LP-BM5 infected mouse brain activates ionotropic glutamate receptors. Neurobiol. Dis.8(6), 1069–1081 (2001).
   PubMedGoogle Scholar
• Whitney KD, McNamara JO. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins. J. Neurosci.20(19), 7307–7316 (2000).
   PubMedGoogle Scholar
• Wenthold RJ, Petralia RS, Blahos J II, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J. Neurosci.16(6), 1982–1989 (1996).
   PubMed Web of Science ®Google Scholar
• Hughes T. The early history of myasthenia gravis. Neuromuscul. Disord.15(12), 878–886 (2005).
   PubMedGoogle Scholar
• Lang B, Pinto A, Giovannini F, Newsom-Davis J, Vincent A. Pathogenic autoantibodies in the lambert-eaton myasthenic syndrome. Ann. NY Acad. Sci.998, 187–195 (2003).
   PubMedGoogle Scholar
• Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain125(Pt 8), 1887–1895 (2002).
   PubMed Web of Science ®Google Scholar
• He XP, Patel M, Whitney KD, Janumpalli S, Tenner A, McNamara JO. Glutamate receptor GluR3 antibodies and death of cortical cells. Neuron20(1), 153–163 (1998).
   PubMed Web of Science ®Google Scholar
• Ganor Y, Gottlieb M, Eilam R, Otmy H, Teichberg VI, Levite M. Immunization with the glutamate receptor-derived peptide GluR3B induces neuronal death and reactive gliosis, but confers partial protection from pentylenetetrazole-induced seizures. Exp. Neurol.195(1), 92–102 (2005).
   PubMedGoogle Scholar
• Ganor Y, Teichberg VI, Levite M. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J. Immunol.178(2), 683–692 (2007).
   PubMedGoogle Scholar
• Takahashi Y, Matsuda K, Kubota Y et al. Vaccination and infection as causative factors in Japanese patients with Rasmussen syndrome: molecular mimicry and HLA class I. Clin. Dev. Immunol.13(2–4), 381–387 (2006).
   PubMedGoogle Scholar
• Gahring L, Carlson NG, Meyer EL, Rogers SW. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J. Immunol.166(3), 1433–1438 (2001).
   PubMed Web of Science ®Google Scholar
• Anthony IC, Crawford DH, Bell JE. B lymphocytes in the normal brain: contrasts with HIV-associated lymphoid infiltrates and lymphomas. Brain126(Pt 5), 1058–1067 (2003).
   PubMed Web of Science ®Google Scholar
• Knopf PM, Harling-Berg CJ, Cserr HF et al. Antigen-dependent intrathecal antibody synthesis in the normal rat brain: tissue entry and local retention of antigen-specific B cells. J. Immunol.161(2), 692–701 (1998).
   PubMed Web of Science ®Google Scholar
• Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res.50(1–2), 105–123 (2002).
   Google Scholar
• Hahn BH. An overview of the pathogenesis of systemic lupus erythematosus. In: Dubois’ Lupus Erythematosus. Wallace DJ, Hahn BH (Eds), Williams and Wilkins, PA, USA, 69–76 (1993).
   Google Scholar
• Winchester RJ. Systemic lupus erythematosus pathogenesis. In: Arthritis and Allied Conditions. Koopman W (Ed.), Williams and Wilkins, AL, USA, 1361–1391 (1996).
   Google Scholar
• Arbuckle MR, McClain MT, Rubertone MV et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med.349(16), 1526–1533 (2003).
   PubMed Web of Science ®Google Scholar
• The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum.42(4), 599–608 (1999).
   PubMed Web of Science ®Google Scholar
• Borchers AT, Aoki CA, Naguwa SM, Keen CL, Shoenfeld Y, Gershwin ME. Neuropsychiatric features of systemic lupus erythematosus. Autoimmun. Rev.4(6), 329–344 (2005).
   PubMedGoogle Scholar
• Tomita M, Khan RL, Blehm BH, Santoro TJ. The potential pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med. Hypotheses62(3), 325–335 (2004).
   PubMedGoogle Scholar
• Hahn BH. Antibodies to DNA. N. Engl. J. Med.338(19), 1359–1368 (1998).
   PubMed Web of Science ®Google Scholar
• Kowal C, DeGiorgio LA, Nakaoka T et al. Cognition and immunity; antibody impairs memory. Immunity21(2), 179–188 (2004).
   PubMed Web of Science ®Google Scholar
• Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc. Natl Acad. Sci. USA103(3), 678–683 (2006).
   PubMed Web of Science ®Google Scholar
• Steup-Beekman G, Steens S, van Buchem M, Huizinga T. Anti-NMDA receptor autoantibodies in patients with systemic lupus erythematosus and their first-degree relatives. Lupus16(5), 329–334 (2007).
   PubMed Web of Science ®Google Scholar
• Shiihara T, Kato M, Konno A, Takahashi Y, Hayasaka K. Acute cerebellar ataxia and consecutive cerebellitis produced by glutamate receptor delta2 autoantibody. Brain Dev.29(4), 254–256 (2007).
   PubMedGoogle Scholar
• Shimokaze T, Kato M, Yoshimura Y, Takahashi Y, Hayasaka K. A case of acute cerebellitis accompanied by autoantibodies against glutamate receptor delta2. Brain Dev.29(4), 224–226 (2007).
   PubMedGoogle Scholar
• Granata T, Fusco L, Gobbi G et al. Experience with immunomodulatory treatments in Rasmussen’s encephalitis. Neurology61(12), 1807–1810 (2003).
   PubMedGoogle Scholar
• Leach JP, Chadwick DW, Miles JB, Hart IK. Improvement in adult-onset Rasmussen’s encephalitis with long-term immunomodulatory therapy. Neurology52(4), 738–742 (1999).
   PubMed Web of Science ®Google Scholar
• Bien CG, Granata T, Antozzi C et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain128(Pt 3), 454–471 (2005).
   PubMed Web of Science ®Google Scholar
• Levite M, Hart IK. Immunotherapy for epilepsy. Expert Rev. Neurother.2(6), 804–819 (2002).
   Google Scholar
• Villani F, Avanzini G. The use of immunoglobulins in the treatment of human epilepsy. Neurol. Sci.23(Suppl. 1), S33–S37 (2002).
   PubMedGoogle Scholar
• Hollmann M, Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci.17, 31–108 (1994).
   PubMed Web of Science ®Google Scholar
• Boulter J, Hollmann M, O’Shea-Greenfield A et al. Molecular cloning and functional expression of glutamate receptor subunit genes. Science249(4972), 1033–1037 (1990).
   PubMed Web of Science ®Google Scholar
• Keinanen K, Wisden W, Sommer B et al. A family of AMPA-selective glutamate receptors. Science249(4968), 556–560 (1990).
   PubMed Web of Science ®Google Scholar
• Madden DR. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci.3(2), 91–101 (2002).
   PubMed Web of Science ®Google Scholar
• Dambinova SA, Izykenova GA, Burov SV, Grigorenko EV, Gromov SA. The presence of autoantibodies to N-terminus domain of GluR1 subunit of AMPA receptor in the blood serum of patients with epilepsy. J. Neurol. Sci.152(1), 93–97 (1997).
   PubMedGoogle Scholar
• Degenhardt A, Duvoisin RM, Frennier J et al. Absence of antibodies to non-NMDA glutamate-receptor subunits in paraneoplastic cerebellar degeneration. Neurology50(5), 1392–1397 (1998).
   PubMedGoogle Scholar
• Sillevis Smitt P, Kinoshita A, De Leeuw B et al. Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor. N. Engl. J. Med.342(1), 21–27 (2000).
   PubMedGoogle Scholar